Mercer Global Advisors’s Portfolio Building Block World Pharma and Biotech Index ETF PBPH Stock Holding History

Mercer Global Advisors’s Portfolio PBPH Stock Details PBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.9K	Buy	+1,433	New	+$36.5K	﹤0.01%	4462

Other funds holding PBPH

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mercer Global Advisors's PBPH Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) in Q2 2026: 1,433 shares worth $38.9K. The stake represents ﹤0.01% of the portfolio and ranks #4462 among its holdings.

10 funds tracked by Wall St. Rank hold PBPH as of Q2 2026.

Mercer Global Advisors held 1,433 shares of Portfolio Building Block World Pharma and Biotech Index ETF worth $38.9K as of Q2 2026.
Portfolio Building Block World Pharma and Biotech Index ETF was a new Mercer Global Advisors position in Q2 2026.
Portfolio Building Block World Pharma and Biotech Index ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4462 holding.
10 funds tracked by Wall St. Rank held Portfolio Building Block World Pharma and Biotech Index ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.